Companies · Healthtech

Casana Care, Inc.

ROCHESTER · Healthtech · refined from filed group “Other

Diligence memoA one-page analyst read on Casana Care, Inc. — recommendation, valuation, rhythm, risks.
$56.4M
Total raised · real
3
Rounds
1.3×
Latest step-up
Top 9%
Sector rank · raised
Series B
Latest stage · inferred · Tue Jan 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Casana Care, Inc. looks over-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 3.68× the median modeled value of Series B Healthtech companies in 2022–2024 (98 peers) — value vs value, same stage and era.
Dormant
  • Last raise 4.5 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

Casana Care, Inc. is one of 2138 Healthtech companies tracked from ROCHESTER. By capital raised it ranks among the largest (ahead of 92% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
10
Investors (latest)
2022-01-04
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$250M$500M$750M$1.0BSeed · 2019-07-01 Raised $2.0M (real) Modeled valuation $55M (est)$2.0M$55MSeed2019Series A · 2020-07-30 Raised $14M (real) Modeled valuation $316M (est)$14M$316MSeries A2020Series B · 2022-01-04 Raised $30M (real) Modeled valuation $456M (est)$30M$456MSeries B2022Series B · 2022-01-04 Raised $40M (real) Modeled valuation $608M (est)$40M$608MSeries B2022+$14M+$30M+$40MCumulative $86M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$2.0M · 2019
Series A$14.4M · 2020
Series B$30.0M · 2022
Series B extension$40.0M · 2022

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 75%.

Modeled valuation trajectory
$608.0M
Base estimate est.
$94.0M
Conservative case
$1.8B
Upside case
$222.2M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Seed · modeled $55.5M · 2019-07-012019Series A · modeled $315.6M · 2020-07-30Series B · modeled $456.0M · 2022-01-04Series B · modeled $608.0M · 2022-01-042022
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.38×/yr
Annual markup
1.67×/yr upside case
4.5 yr
Elapsed time used
4.5 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
10 mo
Avg between rounds
$22.4M/yr
Capital velocity
7.0 yr
On record since
2019
First round
4
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 13× above median
This company$56.4M
Sector median$4.5M
Latest round — vs other Series B rounds in sector (real $, this stage) 2.2× above median
This company$40.0M
Sector median$18.3M
Modeled value — vs sector median (estimate, all stages) 18× above median
This company$608.0M
Sector median$33.8M

Raised more than 92% of sector peers (real $). Modeled value above 94% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #1 of 98.

This companyCohort peer
$100.0M$1.0B$10.0M$100.0MCapital raised (log)Mendel Health Inc. · Series B Raised $52.7M · modeled $570.9M (est)Bicycle Health Inc. · Series B Raised $61.4M · modeled $492.6M (est)Brave Health, Inc. · Series B Raised $38.6M · modeled $485.7M (est)Flume Health, Inc. · Series B Raised $35.9M · modeled $446.0M (est)Healthy America, LLC · Series B Raised $31.0M · modeled $435.9M (est)Moxe Health Corp · Series B Raised $34.8M · modeled $404.2M (est)Kintsugi Mindful Wellness, Inc. · Series B Raised $25.0M · modeled $370.4M (est)Invoq Health, Inc. · Series B Raised $41.5M · modeled $362.5M (est)Folx Health, Inc. · Series B Raised $59.3M · modeled $355.7M (est)Recuro Health, Inc. · Series B Raised $44.2M · modeled $340.0M (est)Orchard Healthcare, Inc. · Series B Raised $34.8M · modeled $338.9M (est)Casana Care, Inc. (this company) Raised $56.4M · modeled $608.0M (est)Casana Care, Inc.
CompanyStageRaised · realValue · estvs peer med.
Casana Care, Inc. this companySeries B$56.4M$608.0M3.68×
Mendel Health Inc.Series B$52.7M$570.9M3.45×
Bicycle Health Inc.Series B$61.4M$492.6M2.98×
Brave Health, Inc.Series B$38.6M$485.7M2.94×
Flume Health, Inc.Series B$35.9M$446.0M2.70×
Healthy America, LLCSeries B$31.0M$435.9M2.64×
Moxe Health CorpSeries B$34.8M$404.2M2.45×
Kintsugi Mindful Wellness, Inc.Series B$25.0M$370.4M2.24×
Invoq Health, Inc.Series B$41.5M$362.5M2.19×
Folx Health, Inc.Series B$59.3M$355.7M2.15×
Recuro Health, Inc.Series B$44.2M$340.0M2.06×
Orchard Healthcare, Inc.Series B$34.8M$338.9M2.05×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$2.0M2019-07-01$10.0M$55.5M90%
Series A$14.4M2020-07-30$65.5M$315.6M90%
Series B$30.0M2022-01-04$166.7M$456.0M90%
Series B$40.0M2022-01-04$222.2M$608.0M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$2.0M2019-07-01
    • First recorded raise — entered as Seed.
  2. Series A$14.4M2020-07-30
    • Raised 13 mo later, in step with the ~14 mo sector norm.
    • Round 7.2× larger than the prior — scaling up.
  3. Series B$30.0M2022-01-04
    • Raised 17 mo later, in step with the ~14 mo sector norm.
    • Round 2.1× larger than the prior — scaling up.
    • 8 investors on this round.
  4. Series B$40.0M2022-01-04
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.3× larger than the prior — scaling up.
    • 10 investors on this round.
Intelligence
2022 ~Q4
Modeled next raise · ~10mo cadence
$53.3M
Modeled next size est.range $40.0M$85.3M
1.3×
Last step-up
$22.4M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Jeffrey Leiden3 other2022-01
Austin McChord2 other2022-01
Paul Sagan2 other2022-01
Ken H. Rosenfeld1 other2019-07
Khan Siddiqui1 other2022-01
Stephen J. Bruso1 other2022-01
David A. Borkholder2019-07
David Borkholder2022-01
David J. Borkholder2022-01
Jeffrey J. Leiden2022-01
Karl Q. Schwarz2019-07
Khan J. Siddiqui2022-01
Khan M. Siddiqui2020-07
Michael J. Sonnendecker2022-01
Michael Sonnendecker2022-01
Nan A. Jiang2020-07
Nicholas Conn2022-01
Nicholas J. Conn2019-07
Olivia J. Lew2022-01
Olivia Lew2022-01
Paul J. Sagan2022-01
Robert Gibbons2022-01
Stephen M. Gormican2020-07
Registry & provenance

Casana Care, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1789010
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
b.well Connected Health, Inc.HealthtechSeries B$56.4M$572.3Msame sector · same stage
GNS Healthcare, Inc.HealthtechSeries B$56.5M$562.3Msame sector · same stage
Invicta Medical, Inc.HealthtechSeries B$55.2M$296.2Msame sector · same stage
Turquoise Health Co.HealthtechSeries B$55.2M$241.5Msame sector · same stage
Integrated Care Partners, Inc.HealthtechSeries B$55.0M$145.9Msame sector · same stage
Folx Health, Inc.HealthtechSeries B$59.3M$355.7Msame sector · same stage
Sirona Medical, Inc.HealthtechSeries B$53.0M$638.3Msame sector · same stage
Heartbeat Health, Inc.HealthtechSeries B$53.0M$164.7Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Materna Medical IncHealthtechSeries B$77.1M89%
Mamaya Health, LLCHealthtechPre-Seed$3.2M86%
Mamaya Health Inc.HealthtechSeed$7.1M86%
Momtech Inc.Other Health CareSeries A$2.2M85%
Sirona Medical, Inc.HealthtechSeries B$638.3M85%
Carie Health, LLCHealthtechSeed$110.9M85%
Mpirica Health Inc.HealthtechSeries A$2.9M85%
Mae Health, Inc.HealthtechSeed$7.6M84%
Frequently asked
How much funding has Casana Care, Inc. raised?
Casana Care, Inc. has raised approximately $56.4M in disclosed capital across 3 recorded financing rounds, aggregated from public filings.
What is Casana Care, Inc.'s estimated valuation?
Provath's modeled valuation for Casana Care, Inc. is approximately $608.0M (modeled range $94.0M–$1.8B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Casana Care, Inc. at?
Casana Care, Inc.'s latest modeled financing stage is Series B. Its most recent recorded round closed around Tue Jan 04.
What does Casana Care, Inc. do and where is it based?
Casana Care, Inc. operates in the Healthtech sector, based in ROCHESTER.
Explore related

See where Casana Care, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Casana Care, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.